Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection

We report the case of a male infant who had an intravitreal anti-VEGF (aflibercept) injection for the treatment of retinopathy of prematurity at 35-week postmenstrual age. Four days following the injection, retinal imaging demonstrated a yellowish gray blurred mass that extended into the vitreous in...

Full description

Saved in:
Bibliographic Details
Main Authors: Elcin Suren, Ersan Cetinkaya, Mustafa Kalayci, Sariye Elif Özyazıcı Özkan, Mehmet Fatih Kucuk, Muhammet Kazim Erol
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Case Reports in Ophthalmological Medicine
Online Access:http://dx.doi.org/10.1155/2020/8861435
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849305102073987072
author Elcin Suren
Ersan Cetinkaya
Mustafa Kalayci
Sariye Elif Özyazıcı Özkan
Mehmet Fatih Kucuk
Muhammet Kazim Erol
author_facet Elcin Suren
Ersan Cetinkaya
Mustafa Kalayci
Sariye Elif Özyazıcı Özkan
Mehmet Fatih Kucuk
Muhammet Kazim Erol
author_sort Elcin Suren
collection DOAJ
description We report the case of a male infant who had an intravitreal anti-VEGF (aflibercept) injection for the treatment of retinopathy of prematurity at 35-week postmenstrual age. Four days following the injection, retinal imaging demonstrated a yellowish gray blurred mass that extended into the vitreous in the right eye, and the vitreous body was blurred. After two days, despite starting endophthalmitis treatment, there was still no improvement in the retinal lesion. Due to the worsening of the clinical signs, we decided to perform 25-gauge lens-sparing pars plana vitrectomy.
format Article
id doaj-art-3cda81f41d1f4659a3a66f8edbd2d980
institution Kabale University
issn 2090-6722
2090-6730
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Case Reports in Ophthalmological Medicine
spelling doaj-art-3cda81f41d1f4659a3a66f8edbd2d9802025-08-20T03:55:33ZengWileyCase Reports in Ophthalmological Medicine2090-67222090-67302020-01-01202010.1155/2020/88614358861435Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept InjectionElcin Suren0Ersan Cetinkaya1Mustafa Kalayci2Sariye Elif Özyazıcı Özkan3Mehmet Fatih Kucuk4Muhammet Kazim Erol5University of Health Sciences, Antalya Training and Research Hospital, Department of Ophthalmology, Antalya, TurkeyUniversity of Health Sciences, Antalya Training and Research Hospital, Department of Ophthalmology, Antalya, TurkeyUniversity of Health Sciences, Antalya Training and Research Hospital, Department of Ophthalmology, Antalya, TurkeyUniversity of Health Sciences, Antalya Training and Research Hospital, Department of Pediatrics, Antalya, TurkeyUniversity of Health Sciences, Antalya Training and Research Hospital, Department of Ophthalmology, Antalya, TurkeyUniversity of Health Sciences, Antalya Training and Research Hospital, Department of Ophthalmology, Antalya, TurkeyWe report the case of a male infant who had an intravitreal anti-VEGF (aflibercept) injection for the treatment of retinopathy of prematurity at 35-week postmenstrual age. Four days following the injection, retinal imaging demonstrated a yellowish gray blurred mass that extended into the vitreous in the right eye, and the vitreous body was blurred. After two days, despite starting endophthalmitis treatment, there was still no improvement in the retinal lesion. Due to the worsening of the clinical signs, we decided to perform 25-gauge lens-sparing pars plana vitrectomy.http://dx.doi.org/10.1155/2020/8861435
spellingShingle Elcin Suren
Ersan Cetinkaya
Mustafa Kalayci
Sariye Elif Özyazıcı Özkan
Mehmet Fatih Kucuk
Muhammet Kazim Erol
Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection
Case Reports in Ophthalmological Medicine
title Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection
title_full Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection
title_fullStr Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection
title_full_unstemmed Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection
title_short Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection
title_sort endophthalmitis in retinopathy of prematurity after intravitreal aflibercept injection
url http://dx.doi.org/10.1155/2020/8861435
work_keys_str_mv AT elcinsuren endophthalmitisinretinopathyofprematurityafterintravitrealafliberceptinjection
AT ersancetinkaya endophthalmitisinretinopathyofprematurityafterintravitrealafliberceptinjection
AT mustafakalayci endophthalmitisinretinopathyofprematurityafterintravitrealafliberceptinjection
AT sariyeelifozyazıcıozkan endophthalmitisinretinopathyofprematurityafterintravitrealafliberceptinjection
AT mehmetfatihkucuk endophthalmitisinretinopathyofprematurityafterintravitrealafliberceptinjection
AT muhammetkazimerol endophthalmitisinretinopathyofprematurityafterintravitrealafliberceptinjection